A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions

Clinical trial NCT07091669 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07091669
Sponsor: Berlin-Chemie AG Menarini Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Male

Start date: 2025-06-16
Primary completion: 2025-08-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.